@article{ea04b195b7d4492d83f20c18494b091c,
title = "Adalimumab: a new modality for Beh{\c c}et's disease?",
keywords = "Adalimumab, Adult, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal, Humanized, Antirheumatic Agents/therapeutic use, Behcet Syndrome/drug therapy, Drug Evaluation, Female, Humans, Male, Retrospective Studies, Tumor Necrosis Factor-alpha/antagonists \& inhibitors",
author = "\{van Laar\}, \{J A M\} and T Missotten and \{van Daele\}, \{P L A\} and A Jamnitski and Baarsma, \{G S\} and \{van Hagen\}, \{P M\}",
year = "2007",
month = apr,
doi = "10.1136/ard.2006.064279",
language = "English",
volume = "66",
pages = "565--6",
number = "4",
}